PMID- 28679322
OWN - NLM
STAT- MEDLINE
DCOM- 20180831
LR  - 20180831
IS  - 2295-3337 (Electronic)
IS  - 1784-3286 (Linking)
VI  - 73
IP  - 1
DP  - 2018 Feb
TI  - Prevalence and co-prevalence of comorbidities in Belgian patients with type 2 
      diabetes mellitus: a transversal, descriptive study.
PG  - 68-74
LID - 10.1080/17843286.2017.1348710 [doi]
AB  - OBJECTIVES: Most patients with type 2 diabetes mellitus (T2DM) have at least one 
      comorbid chronic disease. These comorbidities increase disease burden and costs 
      and may impact the selection of glucose-lowering therapies. The aim of our study 
      was to describe the prevalence and co-prevalence of comorbidities in patients 
      with T2DM in Belgium. METHODS: This was a single centre, transversal, descriptive 
      study performed at Saint-Luc University Hospital, Brussels, Belgium. T2DM 
      patients aged >18 years presenting to the outpatient diabetes clinic and 
      regularly followed (>/=1 year) between July 2011 and 2016 were included in the 
      database. Information on descriptive characteristics was collected and several 
      comorbidities were assessed. RESULTS: Overall, 778 patients were included. The 
      median age was 68 years. The most frequently observed comorbidities were 
      hypertension (85.5%), metabolic syndrome (MetS; 84.6%) and non-alcoholic hepatic 
      steatosis (71.7%). 78.5% of the T2DM patients had >/=4 comorbidities. The highest 
      co-prevalence of comorbidities was the combination of MetS and hypertension 
      (75.8%), MetS and overweight (60.5%), and hypertension and overweight (56.6%). 
      CONCLUSION: The observed prevalence and co-prevalence of comorbidities in T2DM 
      Belgian patients was high, with 95.0% patients having at least two comorbid 
      conditions.
FAU - Hermans, Michel P
AU  - Hermans MP
AD  - a Cliniques Universitaires Saint-Luc , Brussels , Belgium.
FAU - Dath, Nicolas
AU  - Dath N
AD  - b DBexpertise , Brussels , Belgium.
LA  - eng
PT  - Journal Article
DEP - 20170705
PL  - England
TA  - Acta Clin Belg
JT  - Acta clinica Belgica
JID - 0370306
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Belgium/epidemiology
MH  - *Comorbidity
MH  - Diabetes Mellitus, Type 2/*epidemiology
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prevalence
OTO - NOTNLM
OT  - Belgium
OT  - Type 2 diabetes mellitus
OT  - comorbidities
OT  - prevalence
EDAT- 2017/07/07 06:00
MHDA- 2018/09/01 06:00
CRDT- 2017/07/07 06:00
PHST- 2017/07/07 06:00 [pubmed]
PHST- 2018/09/01 06:00 [medline]
PHST- 2017/07/07 06:00 [entrez]
AID - 10.1080/17843286.2017.1348710 [doi]
PST - ppublish
SO  - Acta Clin Belg. 2018 Feb;73(1):68-74. doi: 10.1080/17843286.2017.1348710. Epub 
      2017 Jul 5.